Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody

• Published in: PloS one Vol. 10; no. 10; p. e0140597
• Main Authors: Torkashvand, Fatemeh, Vaziri, Behrouz, Maleknia, Shayan, Heydari, Amir, Vossoughi, Manouchehr, Davami, Fatemeh, Mahboudi, Fereidoun
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 19.10.2015; Public Library of Science (PLoS)
• Subjects: Amino acids; Amino Acids - pharmacology; Analysis of Variance; Animals; Arginine; Aspartic acid; Bevacizumab; Bevacizumab - biosynthesis; Bevacizumab - genetics; Biotechnology; Cell culture; Cell Culture Techniques - methods; Cell growth; Charge distribution; CHO Cells; Cricetinae; Cricetulus; Culture media; Culture Media - chemistry; Design of experiments; Dietary supplements; Genetic Engineering; Glutamic acid; Glycan; Glycine; Health aspects; Immunoglobulin G - metabolism; Laboratories; Low molecular weights; Media (culture); Metabolism; Molecular weight; Molecular weight distribution; Monoclonal antibodies; Optimization; Petroleum engineering; Polysaccharides - metabolism; Productivity; Promotion; Proteins; Quality; Quality management; Recombinant proteins; Response surface methodology; Strategy; Germany; Iran; United States > US
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0140597

Cell culture feeds optimization is a critical step in process development of pharmaceutical recombinant protein production. Amino acids are the basic supplements of mammalian cell culture feeds with known effect on their growth promotion and productivity. In this study, we reported the implementation of the Plackett-Burman (PB) multifactorial design to screen the effects of amino acids on the growth promotion and productivity of a Chinese hamster ovary DG-44 (CHO-DG44) cell line producing bevacizumab. After this screening, the amino acid combinations were optimized by the response surface methodology (RSM) to determine the most effective concentration in feeds. Through this strategy, the final monoclonal antibody (mAb) titre was enhanced by 70%, compared to the control group. For this particular cell line, aspartic acid, glutamic acid, arginine and glycine had the highest positive effects on the final mAb titre. Simultaneously, the impact of the designed amino acid feed on some critical quality attributes of bevacizumab was examined in the group with highest productivity. The product was analysed for N-glycan profiles, charge variant distribution, and low molecular weight forms. The results showed that the target product quality has been improved using this feeding strategy. It was shown how this strategy could significantly diminish the time and number of experiments in identifying the most effective amino acids and related concentrations in target product enhancement. This model could be successfully applied to other components of culture media and feeds.